Friday, 8 November 2024

Medical Fluoropolymers Market Predicted to Witness Steady Growth During the Forecast Period

 Medical Fluoropolymers Market Growth & Trends

The global medical fluoropolymers market size is expected to reach USD 962.03 million by 2030, expanding at 9.2% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for advanced medical technology and devices and growing healthcare investments in emerging economies is expected to drive the demand for medical fluoropolymers over the forecast period.

The medical fluoropolymers industry is also expected to witness high adoption of fluoropolymers in implants on account of their chemical inertness and superior fatigue resistance. The demand for medical device packaging is likely to be driven by the rise in the demand for in-house and advanced medical devices.

The global fluoropolymers industry is one of the most heavily regulated in the world. It will be driven by increasing fluoropolymers consumption in construction, automotive, medical devices, and electrical & electronics applications. A large number of players are operating in the market across the globe, with various types of fluoropolymers, such as polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF), fluorinated ethylene–propylene (FEP), fluoroelastomers, and others are included as product segments. Other product types include ECTFE, PVF, ETFE, PFA, CTFE-VDF, PCTFE, and THV.

Fluoropolymers have been in high demand as substitutes for alloys and metals in a variety of industries, including industrial machinery, consumer goods, and automobiles in recent years. The industry's criticality rests in technological advancement, as end customers' ever-increasing demands for adaptability and product specification steadily drive the consumer electronics sector.

Other elements that influence industry trends include industrial procedures, feedstock availability, and sociopolitical events. Rapid modernization and availability of trained labor in Asia Pacific's growing economies have fueled the region's manufacturing sector's growth. The global epidemic of highly contagious COVID-19, on the other hand, had a significant impact on manufacturing industries, which, in turn, harmed the growth of the global fluoropolymers industry. Work-from-home policies, order cancellations, and shipping issues are all on the rise in the industry as a result of the pandemic's global spread.

Request a free sample copy or view report summary: Medical Fluoropolymers Market Report

Medical Fluoropolymers Market Report Highlights

  • The global medical fluoropolymers industry was valued at USD 475.18 million in 2022 and is estimated to grow at a CAGR of 9.2% from 2023 to 2030
  • In terms of revenue, the polytetrafluoroethylene (PTFE) product segment accounted for a significant share of the market in 2022 and is further expected to witness prominent growth over the forecast period. The growth of PTFE can be attributed to its easy blending properties with numerous fillers such as carbon graphite, glass bead, and molybdenum disulfide for enhancing certain end-use applications
  • The medical tubing application segment dominated the global market and accounted for more than 37.0% of the market revenue share in 2022. Medical tubing is designed for several applications such as anesthesiology, respiratory equipment, peristaltic pumps, biopsy, and check pump functions. It is also used for diagnosing congenital heart defects to allow clinicians to administer fluids and devices or to enable gas flow
  • In 2022, North America accounted for more than 41.0% share of the overall market in terms of revenue. The medical fluoropolymers industry in North America is projected to witness significant growth in the coming years owing to the increased demand for medical fluoropolymers for developing drug delivery devices, medical tubing, catheters, medical bags, etc
  • Various strategic initiatives were recorded over the past few years to boost the growth of medical fluoropolymers. For instance, in November 2020, Mueller Corporation launched a new suite of fluoropolymer coatings for medical devices including polytetrafluoroethylene (PTFE), perfluoro alkoxy (PFA), and fluorinated ethylene propylene (FEP) to their existing portfolio

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-fluoropolymers-market

Medical Fluoropolymers Market Segmentation

Grand View Research has segmented the global medical fluoropolymers market based on product, application, and region:

Medical Fluoropolymers Product Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

  • Ethylene Tetrafluoroethylene (ETFE)
  • Polytetrafluoroethylene (PTFE)
  • Polyvinylidene Fluoride (PVDF)
  • Fluoroelastomers
  • Others

Medical Fluoropolymers Application Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

  • Medical Tubing
  • Catheters
  • Medical Bags
  • Drug Delivery Device
  • Others

Medical Fluoropolymers Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2019 - 2030)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK.
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Central & South America
    • Brazil
  • Middle East & Africa
    • GCC Countries

List of Key Players in Medical Fluoropolymers Market

  • Daikin Industries, Ltd.
  • The Chemours Company
  • Solvay SA
  • Arkema
  • Adtech Polymer Engineering Ltd.
  • Dongyue Group Limited
  • Saint-Gobain
  • L. Gore & Associates, Inc.
  • Hitachi, Ltd.
  • Holscot Fluoropolymers Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Alzheimer’s Therapeutics Market To Make Great Impact In The Near Future by 2030: Grand View Research Inc.

 Alzheimer’s Therapeutics Market Growth & Trends 

The global Alzheimer’s therapeutics market size is expected to reach USD 15.19 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.99% from 2023 to 2030. Government organizations are engaged in providing funds for Alzheimer's support, care, and research activities, which is projected to fuel the market growth. For instance, in March 2022, the Alzheimer's Society announced to spend around USD 3.5 billion in the coming years on dementia research to improve the care of patients.

Additionally, the Alzheimer's Association with the Alzheimer's Impact Movement (AIM) announced to utilize USD 25 million to implement the BOLD Infrastructure for Alzheimer's Act to create an effective public health substructure for patients. In addition, in September 2021, the South Texas Alzheimer's Disease Center and the Duke/University of North Carolina Alzheimer's Disease Research Center were granted USD 14.8 million over five years by the National Institute of Aging to encourage research on risk factors related to AD. 

Furthermore, an increase in the incidence and cost burden of dementia associated with AD is expected to boost the market growth. According to the Alzheimer's Society, around 900,000 people are living with dementia in the United Kingdom, and it is projected to rise to 1.6 million by 2040 and the incidence of dementia will be 209,600 in the same year. 

The current standard of care is limited to symptom-relieving drugs. Therefore, the approval of disease-modifying anti-amyloid therapeutics is expected to change the treatment landscape. For instance, in June 2021, the U.S. FDA granted accelerated approval to Aduhelm (aducanumab) for the treatment of patients with Alzheimer’s disease. It is a monoclonal antibody that targets cluster forms of amyloid beta present in the brains of patients and stops its formation. Other key anti-amyloid monoclonal antibodies in late-stage clinical trials include Gantenerumab (F. Hoffmann-La Roche Ltd.), Solanezumab (Eli Lilly and Company), and Lecanemab (Eisai Inc./Biogen), among others.  

Request a free sample copy or view the report summary: Alzheimer's Therapeutics Market Report

Alzheimer's Therapeutics Market Report Highlights

  • By product, the cholinesterase inhibitors segment held the largest revenue share in 2022 as it is the current standard of care. In March 2022, the U.S. FDA approved the cholinesterase inhibitor Adlarity (donepezil hydrochloride) developed by Corium Inc. for the treatment of patients with AD
  • Pipeline drugs are anticipated to witness the fastest growth over the forecast period due to the presence of a strong product pipeline and their expected launch during the forecast period. Biogen’s product lecanemab (BAN2401), an anti-amyloid beta protofibril antibody for treating AD, is currently in phase 3 clinical trials
  • The hospital pharmacy end-user segment dominated the market in 2022 owing to the high hospitalization rate. According to Alzheimer’s Association report 2022, approximately 32% of total Medicare beneficiaries with Alzheimer’s have at least one hospital discharge annually

Access Press Release@ https://www.grandviewresearch.com/press-release/global-alzheimers-therapeutics-market

Alzheimer's Therapeutics Market Segmentation

Grand View Research has segmented the global Alzheimer’s therapeutics market by product, end-user, and region:

Alzheimer's Therapeutics Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Cholinesterase inhibitors
    • Donepezil
    • Galantamine
    • Rivastigmine
  • NMDA Receptor Antagonist
  • Combination Drug
  • Pipeline Drugs

Alzheimer's Therapeutics End-user Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-commerce

Alzheimer's Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK.
    • Spain
    • France
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Thailand
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

List of Key Players in Alzheimer's Therapeutics Market

  • Eisai Co., Ltd.
  • Novartis AG
  • AbbVie Inc. (Allergan Plc.)
  • Adamas Pharmaceuticals, Inc.
  • Lundbeck A/S
  • Biogen
  • AC Immune
  • Hoffmann La Roche Ltd.
  • Daiichi Sankyo Company, Limited
  • Johnson & Johnson Services, Inc.
  • TauRx Pharmaceuticals Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Electrophysiology Devices Market Strong Application and Emerging Trends also Scope by 2030: Grand View Research Inc.

 Electrophysiology Devices Market Growth & Trends

The global electrophysiology devices market size is expected to reach USD 30.09 billion by 2030, expanding at a CAGR of 15.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The demand for electrophysiology procedures is expected to increase owing to the growing geriatric population and frequent cardiac arrhythmias incidents. According to the World Health Organization, the population aged 60 years and above was approximately 1 billion in 2020 and is expected to reach 1.4 billion by 2030. The adoption of diagnostics and ablation techniques among medical professionals has resulted in the high usage of EP products in the past few years and is likely to drive market growth. The development of new products, such as Nanostim-dual-chamber leadless pacemakers, is anticipated to fuel demand for EP products.

Cardiac ablation has gained popularity as the first-line treatment, rendering a 95% success rate for several rhythm disorders, which, in turn, is boosting its demand. Technological developments, such as laser ablation, cryo-ablation, and ultrasound ablation, coupled with optimized mapping techniques are anticipated to augment market growth over the forecast period. For instance, in September 2020, Koninklijke Philips N.V. released new imaging and workflow enhancements for their novel Kodex-EPD cardiac imaging and mapping system. The market was profusely impacted by the COVID-19 pandemic. Disruptions in the supply chain and postponement of elective surgeries declined the sales of EP systems. According to a study published in the Journal of Cardiothoracic Surgery, approximately 50 to 75% of reduction in cardiac surgeries was reported during the pandemic.

The market is now revamped owing to the adoption of digital health and technological advancements in cardiac surgeries. Moreover, virtual clinics were launched for patients suffering from Atrial Fibrillation(AFib) during the pandemic. For instance, in April 2020, the Physician-Patient Alliance for Health and Safety launched Virtual Patient Care for patients suffering from AFib and had treatment with electrophysiology systems. Prominent players are adopting various strategies including new product launches andM&As to strengthen their position. For instance, in June 2020, Boston Scientific Corp. launched Directsense Technology in the U.S. It will monitor the radiofrequency energy delivery effects during the procedures for cardiac ablation. Directsense technology was approved by the U.S. FDA in April 2020 and is available on RHYTHMIA HDx Mapping System.

Request a free sample copy or view report summary: Electrophysiology Devices Market Report

Electrophysiology Devices Market Report Highlights

  • Based on type, the ablation catheter segment accounted for the largest share of 45.53% of the market in 2024 due to growing heart failure and arrhythmia incidences, awareness regarding the electrophysiology procedures’ reliability, and advancement in EP technologies
  • Based on indication, the atrial fibrillation segment accounted for the largest market share in 2024. It is estimated to register the fastest CAGR of 15.6% during the forecast period. It is the most common type of arrhythmia associated with a high risk of stroke and blood clotting
  • Inpatient facilities accounted for the largest end-use segment with over 83.47% share in 2024, attributed to the high number of surgeries performed in hospitals
  • North America dominated the market with a revenue share of over 49.45% in 2024, due to the high prevalence of heart failure, growing aging population, and robust healthcare system.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-electrophysiology-devices-market

Electrophysiology Devices Market Segmentation

Grand View Research has segmented the global electrophysiology devices market report based on the device type, indication, end use, and region:

Electrophysiology Devices Device Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Ablation Catheters
    • Radiofrequency (RF) Ablation
    • Cryoablation
    • Pulse Field Ablation
  • Diagnostic Catheters
  • Laboratory Devices
  • Access Devices

Electrophysiology Devices Indication Outlook (Revenue, USD Billion, 2018 - 2030)

  • Atrial Fibrillation (AF)
  • Non-Atrial Fibrillation

Electrophysiology Devices End Use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Inpatient Facilities
  • Outpatient Facilities
  • Others

Electrophysiology Devices Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

List of Key Players of Electrophysiology Devices Market

  • Boston Scientific Corp.
  • Medtronic
  • Abbott
  • Biosense Webster (Johnson & Johnson Services, Inc.)
  • Biotronik
  • General Electric Company
  • Siemens Healthcare AG
  • MicroPort Scientific Corporation
  • Koninklijke Philips N.V

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Fluoropolymers Market Predicted to Witness Steady Growth During the Forecast Period

  Medical Fluoropolymers Market Growth & Trends The global  medical fluoropolymers market  size is expected to reach USD 962.03 million ...